Surgical Innovations Group plc
("SI Group" or "the Company")
Director/PDMR Shareholding
The Company was notified on 11 November 2019 that on 6 November 2019 Paul Hardy, Non-Executive Director of the Company, purchased 200,000 ordinary shares of 1 penny each in the Company ("Shares") at a price of 2.5p per Share.
Following the transaction, the combined beneficial holding of Paul Hardy is 7,108,711 Shares, representing approximately 0.89% of the issued share capital of the Company.
For further information please contact:
Surgical Innovations Group Plc |
||
Nigel Rogers, Non-Executive Chairman |
Tel: 0113 230 7597 |
|
Charmaine Day, GFC & Company Secretary |
|
|
|
|
|
N+1 Singer (NOMAD & Broker) |
|
|
Richard Lindley Rachel Hayes
|
Tel: 020 7496 3000
|
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: 020 7933 8780 or si@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
a) |
Name |
Paul Hardy |
|||
2 |
Reason for the notification |
||||
a) |
Position/status |
Non-Executive Director |
|||
b) |
Initial notification/ Amendment |
Initial Notification |
|||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
Surgical Innovations Group plc |
|||
b) |
LEI |
2138004GHGUH3HUZE156 |
|||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p
GB0004016704 |
|||
b) |
Nature of the transactions |
Purchase of Ordinary Shares |
|||
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
2.5p |
200,000 |
||||
|
|||||
d) |
Aggregated information - Aggregated volume - Price |
200,000 £5,000 |
|||
e) |
Date of the transaction |
6 November 2019
|
|||
f) |
Place of the transaction |
London Stock Exchange, AIM
|